These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20401969)

  • 1. Droperidol use in pediatric emergency department patients.
    Szwak K; Sacchetti A
    Pediatr Emerg Care; 2010 Apr; 26(4):248-50. PubMed ID: 20401969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of droperidol in a United States emergency department.
    Gaw CM; Cabrera D; Bellolio F; Mattson AE; Lohse CM; Jeffery MM
    Am J Emerg Med; 2020 Jul; 38(7):1310-1314. PubMed ID: 31831345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Large Retrospective Cohort of Patients Receiving Intravenous Olanzapine in the Emergency Department.
    Martel ML; Klein LR; Rivard RL; Cole JB
    Acad Emerg Med; 2016 Jan; 23(1):29-35. PubMed ID: 26720055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol.
    Richards JR; Derlet RW; Duncan DR
    J Emerg Med; 1998; 16(4):567-73. PubMed ID: 9696171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam.
    Martel M; Sterzinger A; Miner J; Clinton J; Biros M
    Acad Emerg Med; 2005 Dec; 12(12):1167-72. PubMed ID: 16282517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of postoperative nausea and vomiting to determine antiemetic activity of droperidol added to propofol: a possible drug interaction.
    Wagner BK; Berman SL; Devitt PA; O'Hara DA
    Pharmacotherapy; 1994; 14(5):586-91. PubMed ID: 7997392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Chan EW; Taylor DM; Knott JC; Phillips GA; Castle DJ; Kong DC
    Ann Emerg Med; 2013 Jan; 61(1):72-81. PubMed ID: 22981685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of droperidol for the control of acutely agitated out-of-hospital patients.
    Martel M; Miner J; Fringer R; Sufka K; Miamen A; Ho J; Clinton J; Biros M
    Prehosp Emerg Care; 2005; 9(1):44-8. PubMed ID: 16036827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating primary headaches in the ED: can droperidol regain its role?
    Faine B; Hogrefe C; Van Heukelom J; Smelser J
    Am J Emerg Med; 2012 Sep; 30(7):1255-62. PubMed ID: 22030187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of haloperidol plus lorazepam versus droperidol plus midazolam for the treatment of acute agitation in the emergency department.
    Thiemann P; Roy D; Huecker M; Senn J; Javed J; Thomas A; Shreffler J; Shaw I
    Am J Emerg Med; 2022 May; 55():76-81. PubMed ID: 35287091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral Antipsychotic Choice and Its Association With Emergency Department Length of Stay for Acute Agitation Secondary to Alcohol Intoxication.
    Cole JB; Klein LR; Martel ML
    Acad Emerg Med; 2019 Jan; 26(1):79-84. PubMed ID: 29851193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reintegrating droperidol into emergency medicine practice.
    Mattson A; Friend K; Brown CS; Cabrera D
    Am J Health Syst Pharm; 2020 Oct; 77(22):1838-1845. PubMed ID: 32839811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of ketamine versus droperidol on time to restraint removal in agitated emergency department patients.
    Krenz JR; Medeiros K; Lupez K
    Am J Emerg Med; 2023 Jul; 69():23-27. PubMed ID: 37031618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Droperidol analgesia for opioid-tolerant patients.
    Richards JR; Richards IN; Ozery G; Derlet RW
    J Emerg Med; 2011 Oct; 41(4):389-96. PubMed ID: 20832967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Academy of Emergency Medicine Position Statement: Safety of Droperidol Use in the Emergency Department.
    Perkins J; Ho JD; Vilke GM; DeMers G
    J Emerg Med; 2015 Jul; 49(1):91-7. PubMed ID: 25837231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of severe emergence agitation using droperidol.
    Hatzakorzian R; Shan WL; Côté AV; Schricker T; Backman SB
    Anaesthesia; 2006 Nov; 61(11):1112-5. PubMed ID: 17042853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Droperidol and Midazolam Versus Haloperidol and Lorazepam for Acute Agitation Management in the Emergency Department.
    Allen PJ; Johanson KE; Reveles KR; Neff LA; Lock AE
    Ann Pharmacother; 2023 Dec; 57(12):1367-1374. PubMed ID: 36999520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiemetic therapy for nausea and vomiting in the emergency department.
    Patanwala AE; Amini R; Hays DP; Rosen P
    J Emerg Med; 2010 Sep; 39(3):330-6. PubMed ID: 20022195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use, Safety, and Efficacy of Olanzapine in a Level I Pediatric Trauma Center Emergency Department Over a 10-Year Period.
    Cole JB; Klein LR; Strobel AM; Blanchard SR; Nahum R; Martel ML
    Pediatr Emerg Care; 2020 Feb; 36(2):70-76. PubMed ID: 28697164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Droperidol vs prochlorperazine for the treatment of acute headache.
    Weaver CS; Jones JB; Chisholm CD; Foley MJ; Giles BK; Somerville GG; Brizendine EJ; Cordell WH
    J Emerg Med; 2004 Feb; 26(2):145-50. PubMed ID: 14980334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.